Brain Imaging Study of F17464

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01689038

Enrollment

Registered

2012-09-20

Start date

2012-11-30

Completion date

2013-02-28

Last updated

2013-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.

Interventions

DRUGF17464

Single dose

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Male healthy volunteers

Exclusion criteria

* Presence or positive history of severe medical illness or psychiatric conditions

Design outcomes

Primary

Measure	Time frame	Description
Binding rate to cerebral receptors	up to 29 hours	by brain imaging

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026